News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR among country’s top universities in first Knowledge Exchange Framework
The Institute of Cancer Research, London, has ranked highly in the UK’s first Knowledge Exchange Framework (KEF), a new Government assessment of universities’ partnerships and their influence on wider society.
Prince of Wales visits the Breast Cancer Now Toby Robins Research Centre at ICR
Today, His Royal Highness The Prince of Wales visited the Breast Cancer Now Toby Robins Research Centre, at The Institute of Cancer Research, London, 21 years after he officially opened it as the UK’s first dedicated breast cancer research centre in 1999.
Leading breast cancer researcher elected as Fellow of the Academy of Medical Sciences
Professor Nicholas Turner has been recognised with a prestigious Fellowship of the Academy of Medical Sciences for his excellence in breast cancer research and outstanding contribution to the field.
New type of treatment could reawaken immune response against prostate cancer
Targeting a molecule on the surface of immune cells could offer an exciting new way to treat prostate cancer by reawakening the immune response against it.
ICR announces appointment of new Chief Executive
Professor Kristian Helin, a world-leading cancer researcher with exceptional leadership experience in three different countries, will become Chief Executive of The Institute of Cancer Research, London, in September.
Ovarian cancer drug offers new genetically targeted approach against range of cancers
A type of drug used against ovarian and breast cancers could offer a brand new targeted approach for treating a range of cancers with particular genetic defects, including a common form of kidney cancer.
First Covid jab provides protection for most myeloma blood cancer patients
A single dose of a Covid-19 vaccine triggers an immune response in around 70 per cent of patients with myeloma – suggesting that it does provide protection against the virus.
Cancer researchers work through night as pandemic restricts access to labs
The number of scientists able to access labs dropped by almost 30 per cent when the latest coronavirus lockdown was announced, according to new data released by the ICR. Some 28% are therefore resorting to working in unsociable hours to keep their research going. The ICR is calling for financial support to avert a two-year delay in cancer research advances reaching patients.
ICR alumni inspire the next generation at the 2021 Student Conference
At this year’s virtual event, our current PhD students had the opportunity to meet with ICR alumni and ask them about their careers.
Advanced radiotherapy ‘must play central role’ in clearing Covid’s cancer backlog
Urgent investment is needed in advanced forms of radiotherapy so the high-tech treatment can play a central role in clearing the backlog in NHS cancer care that has built up during the pandemic.
AACR Annual Meeting 2021: Immunotherapy combination shows early promise in aggressive brain cancers
Immunotherapy together with an experimental cancer drug could offer a new way of treating some patients with aggressive brain cancers, promising early results from a Phase I trial presented at the 2021 AACR conference suggest.
Gene mutations linked with death from infection in patients with chronic lymphocytic leukaemia
Death from infection – the leading cause of death for patients with a common type of leukaemia – is linked to specific gene mutations, a new study has found.
